Evaluation of the therapeutic benefit of rPMS applied to the trapezius muscle to treat migraine combined with myofascial pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00019870

Enrollment

Registered

2019-11-15

Start date

2017-11-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43 M79

Interventions

Group 1: Stimulation of myofascial trigger points of the trapezius muscle by rPMS (six sessions over two weeks), evaluations of symptoms over 90 days before and after stimulation (headache diary of th

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written informed consent; age above 18 years; presence of at least one trigger point within the trapezius muscle; diagnosis of migraine according to the "Essener Kopfschmerzfragebogen"

Exclusion criteria

Exclusion criteria: Other neurological diseases (except for migraine); epilepsia; pregnancy; implanted medical devices; other severe diseases

Design outcomes

Primary

Measure	Time frame
Improvement of symptoms according to the headache diary of the DMKG (as assessed 90 days before and after rPMS).	—

Secondary

Measure	Time frame
Improvement of the peripheral pressure pain threshold of the neck and shoulder musculature (as measured by algometry prior and subsequent to rPMS) & improvement of symptoms according to the MIDAS questionnaire (as assessed 90 days before and after rPMS).	—

Countries

Germany

Contacts

Public ContactNico Sollmann

Abteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, Technische Universität München

nico.sollmann@tum.de08941404651

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026